Bentham Science Logo

Track Your Manuscript:


Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Cancer Drug Targets, Volume 4 - Number 6

Nerve Growth Factor Receptors and Signaling in Breast Cancer

, 4(6): 463 - 470

Laurent Dolle, Eric Adriaenssens, Ikram El Yazidi-Belkoura, Xuefen Le Bourhis, Victor Nurcombe and Hubert Hondermarck


DOI: 10.2174/1568009043332853


Heparin Affin Regulatory Peptide: A New Target for Tumour Therapy?

, 4(6): 471 - 482

E. Papadimitriou, A. Polykratis, M. Hatziapostolou, A. Parthymou, C. Polytarchou and C. Mikelis


DOI: 10.2174/1568009043332835






Mammaglobin-Based Strategies for Treatment of Breast Cancer

, 4(6): 531 - 542

Peter S. Goedegebuure, Mark A. Watson, Carsten T. Viehl and Timothy P. Fleming


DOI: 10.2174/1568009043332862



Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board

COPE Compliant

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.75

Advertisement

CITATION BOOSTERNew Year Offer 2021

Related Journals

Related eBooks

eBooks Catalog